Retrophin, Inc. Business Operations Contracts & Agreements

7 Contracts & Agreements

Browse by Subcategory

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

Amendment No. 1 to the License and Collaboration Agreement, effective as of October 5, 2022, by and between Travere Therapeutics Switzerland GmbH (formerly known as Orphan...

Collaboration Agreements

Retrophin, Inc.

Biotechnology

2023

First Amendment to Master Manufacturing Supply Agreement, effective as of November 14, 2022, between the Company and STA Pharmaceutical Hong Kong Limited, a subsidiary of WuXi...

Supply Agreements

Retrophin, Inc.

Biotechnology

2023

Commercial Supply Agreement, dated December 21, 2021, between the Company and Catalent Pharma Solutions, LLC

Supply Agreements

Retrophin, Inc.

Biotechnology

2022

License and Collaboration Agreement, dated September 15, 2021, by and among Orphan Technologies Limited and Vifor (International) Ltd., and, solely with respect to Article 15, the...

Collaboration Agreements

Retrophin, Inc.

Biotechnology

NY

2021

Master Manufacturing Supply Agreement, dated September 30, 2020, between the Company and STA Pharmaceutical Hong Kong Limited, a subsidiary of WuKi AppTec

Supply Agreements

Retrophin, Inc.

Biotechnology

2020

Open Market Sales Agreement, dated February 24, 2020, by and between Retrophin, Inc. and Jefferies LLC

Sales Agreements

Retrophin, Inc.

Biotechnology

NY

2020

SETTLEMENT AND RELEASE AGREEMENT

Settlement Agreements

Retrophin, Inc.

Biotechnology

NY

2013